Sleep disturbances and glucose homeostasis by Barf, R. Paulien & Scheurink, Anton J.W.
  
 University of Groningen
Sleep disturbances and glucose homeostasis
Barf, R. Paulien; Scheurink, Anton J.W.
Published in:
European Endocrinology
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2011
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Barf, R. P., & Scheurink, A. J. W. (2011). Sleep disturbances and glucose homeostasis. European
Endocrinology, 7(1), 14-18.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Sleep Disturbances and Glucose Homeostasis
R Paul ien Barf 1 and Anton JW Scheur ink 2
1. PhD Student; 2. Professor of Neuroendocrinology, Department of Neuroendocrinology, Centre for Behaviour and Neurosciences, University of Groningen
Abstract
Sleep disturbances, induced by either lifestyle, shift work or sleeping disorders, have become more prevalent in our 24/7 Western society.
Sleep disturbances are associated with impaired health including metabolic diseases such as obesity and type 2 diabetes. The question
remains whether there is a direct effect of disturbed sleep on glucose homeostasis. Experimental studies under controlled laboratory
conditions in both humans and experimental animals revealed that there are differences between the effects of acute or chronic sleep
disturbance. Acute sleep restriction clearly leads to glucose intolerance, often combined with insulin resistance. Although glucose
intolerance does also occur after chronic sleep disturbance, the changes in insulin can vary, dependent on the body weight changes in the
various studies. The underlying mechanism that might cause the changes in glucose homeostasis after sleep disturbance remains unclear,
but both the biological clock located in the nucleus suprachiasmaticus as well as orexinergic mechanisms in brain and periphery seem to
be involved.
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Over the past 50 years, average sleep duration in Western societies
has decreased by two hours per night.1 Initially, this decrease in sleep
was observed mainly in adulthood, but recent epidemiological
studies have shown a similar decrease in children and adolescents.2,3
A decrease in sleep includes not only the duration, but also the
quality of sleep. Quality of sleep is generally defined in terms of
changes in sleep architecture, the content of dreaming and the
amount of awakenings.4
A decrease in length or quality of sleep has important consequences
for an individual’s well-being. Sleeping problems are linked to many
health and lifestyle problems, such as increased errors, loss of
productivity, sleepiness during the day, impaired social activities
and an elevated risk of accidents.5,6 Disturbed sleep has also been
identified as a risk factor for a variety of diseases, including
psychiatric disorders such as depression7–9 and immune system
dysfunctions.10–12 These health problems are increasing as sleep loss
and decreased sleep quality become more prevalent in our current
24/7 Western society. 
Metabolic Consequences of Sleep Disturbances
Sleep disturbances are also linked to metabolic dysfunctioning.
Studies in shift workers provided the first (indirect) evidence for a
relationship between sleep disturbances and impaired metabolism.
Shift work has become more prevalent during the past decades and
shows clear negative effects on sleep timing, length and quality.13
Shift workers are active during the night and sleep and eat at
abnormal hours. They fall asleep in the morning, but are awakened
ahead of time owing to their circadian rhythm, causing them to
exhibit sleepiness and reduced performance.14 The shift work-
induced changes, in particular sleep loss and disturbed circadian
rhythmicity in eating and energy expenditure are associated with an
increased susceptibility to develop obesity, type 2 diabetes and
cardiovascular disorders.15,16
There is also a direct correlation between disturbed sleep and
obesity, the main risk factor for developing cardiovascular diseases
and type 2 diabetes. Evidence for this comes from several
epidemiological studies, including those described by Caput and
Van Cauter.17,18 In addition, the group of Gottlieb and co-workers19
provided evidence for a direct correlation between disturbed sleep
and the increased prevalence of type 2 diabetes, independent of
changes in body weight.
Another striking example of the relationship between disturbed
sleep and increased risk for metabolic disorders derives from
studies of patients with obstructive sleep apnoea (OSA). OSA is
characterised by the recurrent collapse of the airway during sleep,
which usually leads to arousals to resume breathing. The patients
suffer from sleep fragmentation and hypoxemia, causing disturbed
sleep architecture and an increased amount of awakenings.20,21 OSA
primarily changes the quality of sleep, whereas total sleep time is
not dramatically altered. Vgontzas and colleagues22 were the first to
show that there is a relation between OSA and obesity, type 2
diabetes and cardiovascular disease. In fact, there is a bidirectional
relationship: OSA leads to obesity, but obesity also directly affects
OSA: weight gain or weight loss leads to a significant worsening or
improvement, respectively, of sleep apnoea in adults.23,24 OSA is also
directly associated with insulin resistance and glucose intolerance,
independent of changes in weight.25
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Human Studies on Sleep and 
Glucose Homeostasis
The main point of the above is that disturbed sleep is clearly
associated with an increased risk for type 2 diabetes, even when
corrected for body mass indiex (BMI) or fat content of the body.19,26
This leads to the question: is there a direct effect of (disturbed) sleep
on glucose and insulin regulation? To answer this question,
experimental studies under controlled laboratory conditions are
required. These studies, both in humans and experimental animals,
were recently performed in different labs.
In experimental studies in humans, most experimenters standardise
the experimental protocol by providing standard meals at fixed time
points of the day and by requiring the subjects to stay in bed during
the sleep restriction hours to minimise activity. Unfortunately, there
is still large variation in the experimental set up of the sleep
restriction protocols, in particular in the length of the sleep
restriction period, which can vary from acute one night of total sleep
deprivation up to periods of six nights of partial sleep deprivation.
These differences in length of the sleep restriction protocols
markedly influenced the outcomes of the different studies. 
The first experimental study in humans was published in 1993, when
VanHelder and colleagues showed that 60 hours of sleep deprivation
led to an increased plasma insulin response without changes in
blood glucose during an oral glucose tolerance test (OGTT).27 Similar
data after one night of sleep restriction have been found in a recent
study by Donga et al.28 in which insulin sensitivity was measured
with the gold standard method for measuring insulin sensitivity: a
hyperinsulineamic euglycaemic clamp. In this study, one night of
sleep restriction (four hours in bed) was sufficient to develop
moderate insulin resistance, reflected by a decreased glucose
infusion rate, a reduced glucose disposal rate and increased
endogenous glucose production. In this study, the baseline glucose
and insulin levels were not different from controls.
In 1999, Spiegel and colleagues showed that six days of partial sleep
restriction (subjects were allowed to sleep only four hours per night)
led to glucose intolerance reflected by a significant elevation of
blood glucose levels during an intravenous glucose tolerance test
(IVGTT).29 Surprisingly, there was no reduction in insulin sensitivity.
Instead, it was observed that plasma insulin levels were decreased
after six days of sleep disturbance, which is in sharp contrast with
the data from VanHelder and Donga.27,28 However, in a follow-up
study from the same lab,30 the authors found that sleep disturbance
could indeed lead to reduced insulin sensitivity and glucose
intolerance. In this particular study, the subjects were submitted to
an IVGTT and sleep disturbance was defined as three nights of
experimentally suppressed slow-wave sleep without changes in
total sleep time. This also leads to the conclusion that it is not only
the quantity, but also the quality of sleep that is important.
Although many of these human data are seemingly in conflict with
each other, one can still conclude that sleep disturbance has a
marked impact on glucose and insulin homeostasis. When searching
for a common denominator, it seems that acute sleep disturbances
might to lead to insulin resistance and, in some cases, glucose
intolerance, whereas longer periods of disturbed sleep have no
direct effect on insulin sensitivity, but the glucose intolerance
remains. One can speculate that the insulin resistance after acute
total sleep deprivation is secondary to the (stress-induced) elevation
of the hypothalamic–pituitary–adrenal (HPA) axis reflected by the
elevated cortisol levels in the evening after a night without sleep.31
This acute stress response can be less pronounced in the longer
sleep restriction studies, where the subjects are still allowed to
sleep for a few hours per night. However, Spiegel and colleagues29
still found increased cortisol levels after the six days of sleep
restriction, although this increase was less pronounced when
compared with the acute response after one night without sleep.
Animal Studies of Sleep and 
Glucose Homeostasis – Rat Studies
As mentioned above, human studies can vary in length from acute
sleep deprivation to a maximum of up to six days of sleep
restriction. Animal studies are required for studies of chronic sleep
disturbance for investigation of the underlying mechanisms. Most
animal studies in (chronic) sleep research are performed in rodents
and experimental methods to prevent the animals from sleeping
vary from gentle handling to small balance platforms and forced
activity. The different methods are discussed below.
The gentle handling method32 is comparable to the sleep restriction
protocol in human experiments. The animals, mostly rats, are kept
awake by a protocol that includes tapping on the cage, shaking the
cage gently or, if required, disturbing the nest. This method is mainly
used in acute or short-term sleep deprivation experiments, because
the experimenter is required to be present continuously during the
experiments. In our laboratory, 12 hours of sleep deprivation by
means of gentle handling had no effect on baseline levels of blood
glucose, plasma insulin and plasma corticosterone.
The balance platform method is more commonly used in chronic
sleep restriction experiments. Two methods are described in the
literature: the flower pot and the single platform method. Both
methods are used to deprive rats of rapid eye movement (REM)
sleep only and the principle is as follows: to induce REM sleep
deprivation, rats are placed inside a water chamber onto a flower
pot or a platform of approximately 7.0cm in diameter. The platform
is in the water up to 1.0cm of the platform upper surface. The
method is based on the loss of muscle tonus that occurs during REM
sleep. This means that if the rat enters the REM sleep stage, it loses
muscle tonus and will touch the water, after which the rat will wake
up.33 When this method is used to deprive rats of REM sleep for four
days, it leads to a decrease in plasma insulin levels, which is
secondary to a significant reduction in body weight.34
Another commonly used method in animal sleep restriction 
research is the disk over water method, extensively described by
Rechtschaffen and colleagues.35,36 In short, the experimental animal
is housed on a horizontal disk above water. The electromyograph
(EMG) and the electroencephalograph (EEG) are continuously
recorded to detect sleep states. When the experimental rat starts to
sleep or enters a certain sleep stage, the disk starts to rotate at a
low speed. This causes the rat to wake and forces it to walk to avoid
being carried into the water. There is only one study in which this
method was used to investigate glucose homeostasis after a longer
period of sleep deprivation. In this study by Everson and colleagues,
they measured glucose disappearance after a dextrose injection.
The data revealed that there was a tendency towards somewhat
lowered glucose levels after sleep deprivation.37
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In our laboratory, we use a forced activity paradigm known as the
slowly rotating drum to sleep deprive the rats. This method was
originally described in 1984 by Borbely and colleagues.38 In our
studies, the experimental animals are placed for 20 hours per day in
a rotating drum (see Figure 1) that is rotating at a constant speed of
0.4cm/min.39–41 In this way, the animals are allowed to sleep only for
(the remaining) four hours per day. We generally include a control
group that walks twice the speed (0.8cm/min) but half the time to
control for the forced activity in this protocol. Our latest studies
focused on the difference between the effects of acute and chronic
sleep deprivation on glucose homeostasis and insulin levels.39 To
this end, we performed an intravenous glucose tolerance test after
one day and eight days of sleep restriction. The data revealed that a
reduction in sleep markedly interfered with glucose metabolism.39
Acute sleep restriction was accompanied by elevated blood glucose
profiles without any changes in plasma insulin levels during an
IVGTT. The effects of chronic sleep reduction are presented in Figure
2. The observed glucose intolerance is still present after eight days
of sleep restriction, which is similar to the data obtained in most
human studies. Baseline insulin levels and glucose-stimulated
insulin responses were lower after chronic sleep reduction. This
effect on insulin was, similar to the data in humans obtained by
Spiegel et al. in 1999,29 secondary to the weight loss after chronic
sleep reduction.
Based on the data above, we can conclude that the effects of sleep
restriction on glucose homeostasis in experimental animals are
remarkably similar in rats and humans. Acute sleep restriction leads
to glucose intolerance in combination with unchanged insulin levels
(all rat models and some human studies) or insulin resistance (other
human studies). The glucose intolerance remains prevalent after
chronic sleep restriction, both in humans and rats. Chronic sleep
restriction might also lead to a reduction in plasma insulin levels, but
this effect seems secondary to a reduction in body weight. The
reduction in body weight is typical for experimental studies under
controlled conditions and in sharp contrast with epidemiological
data that suggest that long-term sleep disturbances are associated
with weight gain and the development of obesity and, consequently,
of insulin resistance and type 2 diabetes. The insulin resistance that
occurs after one night of total sleep deprivation in the (human)
experimental studies seems primarily caused by a (stress-induced)
activation of the HPA axis, reflected by the elevated cortisol levels
under these circumstances. 
Possible Mechanisms Underlying 
Glucose Intolerance
The data above raise the question: what is the cause of the glucose
intolerance that occurs after both acute and chronic sleep
deprivation? Is it mainly a behavioral effect, related to changes in
food intake, physical activity and energy expenditure? Or is it caused
by (circadian) disturbances in hormonal outflow and/or the
activation of the autonomic nervous system? Or is hyperglycaemia
mainly secondary to changes at the level of the central nervous
system, in particular at orexinergic neurons in the lateral
hypothalamus? Some of these options are discussed below.
The biological clock, located in the suprachiasmatic nucleus (SCN),
has a marked effect on glucose homeostasis. There are clear
differences in the glucose and insulin responses to an IVGTT in both
rats and humans at different times of the circadian clock.42 This
circadian rhythmicity in glucose regulation disappears when the
SCN is lesioned.43 One can state that the biological clock not 
only influences the sleep-wake cycle, but also prepares the glucose
regulatory mechanisms for the changes in energy uptake and
Diabetes Pathophysiology
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Figure 1: Slowly Rotating Drum
Figure 2: Blood Glucose and Plasma Insulin Levels in
Response to a 30-minute Intravenous Glucose Infusion
After Either One (Graphs A and C) and Eight (Graphs B
and D) Days of Restricted Sleep or in Controls
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The horizontal pink bars at the bottom of each graph represent the 30 minutes of 15% 
glucose infusion. Data are average values ± SEM.39
RS = restricted sleep.
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expenditure at different time points of the day/night cycle. These
circadian systems are tightly integrated and problems can occur
when our daily activities are not in synchrony with our sleep–wake
cycle, for example, during shift work and periods of disturbed
sleep.16 For example, when rats are forced to be active in their 
non-active phase, they eat at the wrong time of the day and
consequently increase in body weight compared with controls.44
This weight gain can be prevented when the animals are only
allowed to eat in the (normal) active phase and not in the shift 
work period.45
Hormonal influences also seem to be involved in the effects of
disturbed and restricted sleep in glucose metabolism. In humans,
sleep deprivation has been shown to decrease plasma leptin and to
increase plasma ghrelin levels, leading to increased hunger and
appetite.46 At a central level, the orexinergic system in the brain also
seems to have a role. Orexin is involved in food intake, energy
expenditure and the sleep–wake cycle, and could therefore be an
interesting link between sleep disturbances and the increased
prevalence of obesity and type 2 diabetes.47,48 For example,
narcolepsia is a disease that is characterised by reduced orexin
levels in the central nervous system causing less consolidated wake
periods, leading to a sudden appearance of sleep periods.
Narcolepsia is associated with an increased frequency of type 2
diabetes.49 Peripheral orexin also seems to be involved as orexin
receptors have been found on the pancreas and other peripheral
organs.50 It is also known that orexin has a direct role in the
regulation of glucose homeostasis. Tsuneki and colleagues showed
that orexin neurons directly respond to the nutritional status of an
individual and are modulated by metabolic signals, such as glucose,
leptin and ghrelin.51,52 Studies in orexin knockout mice point to a
contribution of orexin in the age-related development of impaired
glucose tolerance, independent of obesity.53 Finally, it is known that
orexin is directly involved in the regulation of energy expenditure.
Increased orexin levels correspond with increased physical activity
and increased non-exercise thermogenesis (NEAT) and,
consequently, glucose utilisation. Taken together, these data
indicate that orexin might serve as a crucial factor in the relationship
between sleep loss, circadian rhythms, physical activity and the
effects on glucose metabolism (see Figure 3).
In summary, sleep disturbances are directly associated with
changes in glucose homeostasis. Experimental studies under
controlled laboratory conditions in both humans and experimental
animals revealed that there are differences between the effects of
acute or chronic sleep disturbance. Acute sleep restriction clearly
leads to glucose intolerance often combined with insulin resistance.
Glucose intolerance also occurs after chronic sleep disturbance but
the changes in insulin can vary, depending on the body weight
changes in the various studies. The underlying mechanism that
might cause the changes in glucose homeostasis after sleep
disturbance remain unclear, but both the biological clock located in
the nucleus suprachiasmaticus as well as orexinergic mechanisms
in the brain and periphery seem to be involved. n
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